Cross-source identity
National Provider Identifier 1457876591 as it appears in every federal dataset Fonteum holds. Each row is a distinct public source; the chip carries the source and the snapshot date behind that field — the record-level form of the source-provenanced graph.
| Federal source | Key | What it provides | Provenance |
|---|---|---|---|
| CMS Open Payments |
| NPI 1457876591 |
| 116 industry-payment records, 2024 |
| Source:CMS Open PaymentsSnapshot PY2024 |
| CMS Medicare Part D | NPI 1457876591 | 31 drugs prescribed, 2024 | Source:CMS Part DSnapshot DY2024 |
| Fonteum entity graph | entity dde183d2… | Canonical resolved node · 2 identifier(s) · 17 edge(s) | Source:Entity graphSnapshot 2026-06-11 |
Industry payments
Payments and transfers of value this clinician received from drug and device manufacturers, disclosed under the Physician Payments Sunshine Act. A payment is a disclosure, not a judgment.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $2,286 | 116 |
| Manufacturer | Amount | Records |
|---|---|---|
| Lundbeck Llc | $371 | 20 |
| Alkermes, Inc. | $370 | 21 |
| Iti, Inc. (D/B/A Intra-Cellular Therapies, Inc.) | $323 |
Prescribing
Prescriptions written under Medicare Part D, aggregated by drug across the program. Totals reflect claims paid, not patients treated.
| Drug | Claims | Drug cost |
|---|---|---|
| Caplyta(Lumateperone Tosylate) | 32 | $64,164 |
| Vraylar(Cariprazine Hcl) | 18 | $27,421 |
| Lybalvi(Olanzapine/Samidorphan Malate) | 11 | $19,022 |
| Trintellix(Vortioxetine Hydrobromide) | 27 | $13,330 |
| Belsomra(Suvorexant) | 25 | $13,208 |
Beneficiary counts below 11 are suppressed by CMS — the total shown is a lower bound.
Quality
CMS Quality Payment Program Merit-based Incentive Payment System (MIPS) final score, where this clinician participated. Absence of a score is not a quality signal — many clinicians report through a group or are exempt.
Enrollment & sanctions
Screening aid — re-confirm any match against the issuing list before acting. A clean result means no record was found in the federal OIG LEIE or the state Medicaid lists Fonteum currently holds (NY, OH, GA), not a guarantee that none exists elsewhere. Not a legal or credentialing certification.
Ownership & affiliations
One-hop relationships in the resolved entity graph — chain membership, ownership, and operation edges, each backed by a federal source row. Most individual clinicians carry none; edges populate for owners and organizations as the Lane D backfill runs.
| Relationship | Entity | Source |
|---|---|---|
| ← pays | Neos Therapeutics, Lp (CO) | cms_open_payments |
| ← pays | Corium, Llc (MA) | cms_open_payments |
| ← pays | E.R. Squibb & Sons, L.L.C. (NJ) | cms_open_payments |
| ← pays | Abbvie Inc. (IL) | cms_open_payments |
| ← pays | Otsuka America Pharmaceutical, Inc. (MD) | cms_open_payments |
| ← pays | Alkermes, Inc. (MA) | cms_open_payments |
| ← pays | Braeburn Inc. (PA) | cms_open_payments |
| ← pays | Validus Pharmaceuticals Llc (NJ) | cms_open_payments |
| ← pays | Vanda Pharmaceuticals Inc. (DC) | cms_open_payments |
| ← pays | Lilly Usa, Llc (IN) | cms_open_payments |
| ← pays | Takeda Pharmaceuticals U.S.A., Inc. (MA) | cms_open_payments |
| ← pays | Iti, Inc. (D/B/A Intra-Cellular Therapies, Inc.) (NJ) | cms_open_payments |
| ← pays | Indivior Inc. (VA) | cms_open_payments |
| ← pays | Lundbeck Llc (IL) | cms_open_payments |
| ← pays | Ironshore Pharmaceuticals Inc. (NC) | cms_open_payments |
| ← pays | Tris Pharma Inc (NJ) | cms_open_payments |
| ← pays | Axsome Therapeutics, Inc. (NY) | cms_open_payments |
| 17 |
| Otsuka America Pharmaceutical, Inc. | $229 | 10 |
| Braeburn Inc. | $167 | 11 |